Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

Version 1 : Received: 7 December 2023 / Approved: 8 December 2023 / Online: 8 December 2023 (13:59:19 CET)

A peer-reviewed article of this Preprint also exists.

Khamidullina, A.I.; Abramenko, Y.E.; Bruter, A.V.; Tatarskiy, V.V. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. Int. J. Mol. Sci. 2024, 25, 1263. Khamidullina, A.I.; Abramenko, Y.E.; Bruter, A.V.; Tatarskiy, V.V. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. Int. J. Mol. Sci. 2024, 25, 1263.

Abstract

Replication stress (RS) is a characteristic state of cancer cells as they tend to exchange precision of replication for fast proliferation and increased genomic instability. To overcome the consequences of improper replication control malignant cells frequently inactivate parts of their DNA damage response (DDR) pathways (the ATM-CHK2-p53 pathway), while relying on other pathways which help to maintain replication fork stability (ATR-CHK1). This creates a dependency on the remaining DDR pathways, vulnerability to further destabilization of replication and synthetic lethality of DDR inhibitors with common oncogenic alterations such as mutations of TP53, RB1, ATM, amplifications of MYC, CCNE1 and others. The response to RS is normally limited by coordination of cell cycle, transcription and replication. Inhibition of WEE1 and PKMYT1 kinases, which prevent unscheduled mitosis entry, leads to fragility of under-replicated sites. Recent evi-dence also shows that inhibition of Cyclin-dependent kinases (CDKs), such as CDK4/6, CDK2, CDK8/19 and CDK12/13 can contribute to RS through disruption of DNA repair and replication control. Here, we review the main causes of RS in cancers as well as main therapeutic targets – ATR, CHK1, PARP and their inhibitors.

Keywords

replication stress; DNA damage response; ATR; CHK1; PARP; WEE1; PKMYT1; Cyclin dependent kinases

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.